For the year ending 2025-12-31, KURA has $738,363K in assets. $564,228K in debts. $149,099K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 149,099 | |||
| Short-term investments | 518,141 | |||
| Accounts receivable, net | 8,804 | |||
| Inventory | 413 | |||
| Prepaid expenses and other current assets | 32,206 | |||
| Total current assets | 708,663 | |||
| Property and equipment, net | 7,855 | |||
| Operating lease right-of-use assets | 7,302 | |||
| Other long-term assets | 14,543 | |||
| Total assets | 738,363 | |||
| Accounts payable | 5,017 | |||
| Accrued expenses and other current liabilities | 61,697 | |||
| Current operating lease liabilities | 1,277 | |||
| Current portion of long-term debt | 0 | |||
| Current portion of contract liabilities | 48,983 | |||
| Total current liabilities | 116,974 | |||
| Long-term debt, net of current portion | 9,711 | |||
| Long-term operating lease liabilities | 9,469 | |||
| Other long-term liabilities | 3,165 | |||
| Long-term contract liabilities | 424,909 | |||
| Total liabilities | 564,228 | |||
| Common stock, 0.0001 par value 200,000 shares authorized 87,855 and 78,229 shares issued and outstanding as of december 31, 2025 and 2024, respectively | 9 | |||
| Additional paid-in capital | 1,347,190 | |||
| Accumulated other comprehensive income | 1,024 | |||
| Accumulated deficit | -1,174,088 | |||
| Total stockholders' equity | 174,135 | |||
| Total liabilities and stockholders' equity | 738,363 | |||
Kura Oncology, Inc. (KURA)
Kura Oncology, Inc. (KURA)